Genomics

Dataset Information

Pembrolizumab, exemestane, and leuprolide in premenopausal estrogen receptor-positive/HER2-negative advanced breast cancer


ABSTRACT: Pembrolizumab, exemestane, and leuprolide in premenopausal estrogen receptor-positive/HER2-negative advanced breast cancer

PROVIDER: PRJNA1086814 | ENA |

REPOSITORIES: ENA